IBS - Irritable Bowel Syndrome: Clinical Trials

3 trials for IBS - Irritable Bowel Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Unknown 2, Completed 1

Follow IBS - Irritable Bowel Syndrome: new trials by email Literature Review of IBS - Irritable Bowel Syndrome trials Research Report on IBS - Irritable Bowel Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
Tenapanor - IBS, IBS - Irritable Bowel Syndrome
Phase 4CompletedKyle Staller, MD, MPH362024-02-062026-03-12
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Probiotic formulation, Placebo - IBS - Irritable Bowel Syndrome
Phase 4UnknownLallemand Health Solutions1622022-08-112024-02-20
Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
Rifaximin, Probiotic Formula, Placebo oral tablet - IBS - Irritable Bowel Syndrome, Gut Microbiota
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine2402020-05-102020-07-28

Narrower conditions

Irritable Bowel Syndrome (3)

Broader conditions

Colonic Diseases (3)  ·  Colonic Diseases, Functional (3)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)

Interventions

Rifaximin (1)  ·  tenapanor (1)

Sponsors

Kyle Staller, MD, MPH (1)  ·  Lallemand Health Solutions (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Liangjing Wang, Ph.D (1)  ·  Serhat Bor, Prof. Dr. (1)

Results publications

PMID 42609157